VISEN Pharmaceuticals (HKG:2561)
Hong Kong
· Delayed Price · Currency is HKD
25.20
0.00 (0.00%)
Apr 29, 2026, 4:08 PM HKT
VISEN Pharmaceuticals Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | - | -182.24 | -249.57 | -288.97 |
| Depreciation & Amortization | - | 3.95 | 6.15 | 6.67 |
| Other Amortization | - | 0.51 | 0.85 | 0.72 |
| Loss (Gain) From Sale of Assets | - | - | 0.24 | 0.09 |
| Stock-Based Compensation | - | 32.77 | -12.27 | 93.51 |
| Other Operating Activities | - | 2.48 | 67.12 | -0.77 |
| Change in Accounts Payable | - | 1.21 | -12.08 | 4.44 |
| Change in Unearned Revenue | - | -2.9 | - | - |
| Change in Other Net Operating Assets | - | 3.36 | -71.75 | -62.25 |
| Operating Cash Flow | - | -140.86 | -271.31 | -246.55 |
| Capital Expenditures | - | -0.12 | -0.52 | -1.48 |
| Sale (Purchase) of Intangibles | - | - | - | -0.28 |
| Investing Cash Flow | - | -0.12 | -0.52 | -1.77 |
| Long-Term Debt Repaid | - | -3.09 | -4.95 | -5.78 |
| Net Debt Issued (Repaid) | - | -3.09 | -4.95 | -5.78 |
| Other Financing Activities | - | - | -2.01 | -2.17 |
| Financing Cash Flow | - | -3.09 | -6.95 | -7.95 |
| Foreign Exchange Rate Adjustments | - | -0.13 | 0.11 | 0.07 |
| Net Cash Flow | - | -144.2 | -278.68 | -256.2 |
| Free Cash Flow | - | -140.98 | -271.83 | -248.03 |
| Free Cash Flow Margin | - | -5076.52% | - | - |
| Free Cash Flow Per Share | - | -1.51 | -2.90 | - |
| Levered Free Cash Flow | - | -63.57 | -67.66 | - |
| Unlevered Free Cash Flow | - | -63.47 | -67.46 | - |
| Change in Working Capital | - | 1.66 | -83.83 | -57.81 |
Source: S&P Capital IQ. Standard template.
Financial Sources.